Direxion mRNA ETF (MSGR)

NYSEARCA: MSGR · IEX Real-Time Price · USD
19.82 0.06 (0.32%)
Jan 14, 2022 4:00 PM EST - Market closed
Assets$3.45M
NAV$19.69
Expense Ratio0.65%
PE Ration/a
Shares Out175,000
Dividend (ttm)n/a
Dividend Yieldn/a
Ex-Dividend Daten/a
1-Year Return-18.52%
Volume8,617
Open19.71
Previous Close19.75
Day's Range19.82 - 19.82
52-Week Low19.15
52-Week High19.15
Betan/a
Holdings24
Inception DateDec 9, 2021

About MSGR

The Direxion mRNA ETF seeks investment results, before fees and expenses, that track the BITA Messenger RNA Technology Index; investing in U.S., Canadian and European companies that are leading the development of messenger RNA technology.

Asset ClassEquity
IssuerDirexion Investments
Stock ExchangeNYSEARCA
Ticker SymbolMSGR
Index TrackedBITA Messenger RNA Technology Index

Top 10 Holdings

66.54% of assets
NameSymbolWeight
Vertex PharmaceuticalsVRTX12.66%
Alnylam PharmaceuticalsALNY7.51%
BioNTech SEBNTX7.49%
BeiGeneBGNE6.52%
Ionis PharmaceuticalsIONS6.18%
ModernaMRNA5.86%
Arrowhead PharmaceuticalsARWR5.79%
ProQR TherapeuticsPRQR5.17%
Arcturus Therapeutics HoldingsARCT4.72%
Sarepta TherapeuticsSRPT4.64%
View More Holdings

News

Direxion Launches mRNA Technology-Focused ETF

Direxion has announced today in a press release the launch of their newest ETF that focuses on the applications and developments of messenger RNA technology, the Direxion mRNA ETF (MSGR). The fund looks...

1 month ago - ETF Trends

Direxion Launches mRNA ETF (MSGR)

NEW YORK, Dec. 9, 2021 /PRNewswire/ --  Direxion announced today the launch of the Direxion mRNA ETF (Ticker: MSGR) . MSGR invests in companies believed to be at the forefront of the development and app...

1 month ago - PRNewsWire